![Charmaine Gittleson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charmaine Gittleson
Vorsitzender bei
PERCHERON THERAPEUTICS LIMITED
Vermögen: 5 125 $ am 30.06.2026
Profil
Charmaine Gittleson is Non-Executive Chairman at Percheron Therapeutics Ltd. since 2023, Independent Non-Executive Director at Polynovo Ltd. starting 2026, Non-Executive Director at George Medicines Pty Ltd., and Non-Executive Director at Imugene Ltd. starting 2026.
Former roles include Chairman at Patrys Ltd. from 2022 to 2025 and Chief Medical Officer at CSL Ltd. Education includes an undergraduate degree from the University of the Witwatersrand.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.12.2024 | 2.464.000 ( 0,16 % ) | 5 125 $ | 30.06.2026 |
Aktive Positionen von Charmaine Gittleson
| Unternehmen | Position | Beginn |
|---|---|---|
| PERCHERON THERAPEUTICS LIMITED | Vorsitzender | - |
| POLYNOVO LIMITED | Direktor/Vorstandsmitglied | 01.04.2026 |
| IMUGENE LIMITED | Direktor/Vorstandsmitglied | 30.06.2026 |
Ehemalige bekannte Positionen von Charmaine Gittleson
| Unternehmen | Position | Ende |
|---|---|---|
| PATRYS LIMITED | Vorsitzender | 17.06.2025 |
| CSL LIMITED | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Charmaine Gittleson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Percheron Therapeutics Ltd.
 Percheron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes antisense pharmaceuticals | Health Technology |
Patrys Ltd.
 Patrys Ltd. Pharmaceuticals: MajorHealth Technology Develops novel antibody technologies for hard-to-treat cancers | Health Technology |
Imugene Ltd.
 Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
Polynovo Ltd.
 Polynovo Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
University of the Witwatersrand
 University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
